Why DaVita Inc Stock Is Plummeting Today

Core Insights - DaVita Inc's shares experienced a significant decline, losing 11.1% by market close, with an intraday drop of 15.2% [1] - The company's Q4 2024 earnings report showed positive earnings per share (EPS) of $2.24, exceeding analyst estimates of$2.13, with sales of $3.3 billion, surpassing Wall Street targets [2] - However, the company's guidance for 2025 was weaker than expected, projecting EPS between$10.20 and $11.30, below the consensus estimate of$11.24, indicating elevated uncertainty [3] - DaVita reported elevated mortality and mistreatment rates, which could hinder new patient growth [4] - The decline in share price was also influenced by Berkshire Hathaway reducing its stake in DaVita, selling over 200,000 shares while still holding 45% [5]